rs201780665
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_181426.2(CCDC39):c.1795C>T(p.Arg599Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000875 in 1,611,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_181426.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC39 | NM_181426.2 | c.1795C>T | p.Arg599Ter | stop_gained | 13/20 | ENST00000476379.6 | NP_852091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC39 | ENST00000476379.6 | c.1795C>T | p.Arg599Ter | stop_gained | 13/20 | 2 | NM_181426.2 | ENSP00000417960 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000765 AC: 19AN: 248382Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134776
GnomAD4 exome AF: 0.0000918 AC: 134AN: 1459060Hom.: 0 Cov.: 30 AF XY: 0.0000840 AC XY: 61AN XY: 725796
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2021 | The p.R599* pathogenic mutation (also known as c.1795C>T), located in coding exon 13 of the CCDC39 gene, results from a C to T substitution at nucleotide position 1795. This changes the amino acid from an arginine to a stop codon within coding exon 13. This mutation has been reported in one homozgyous and two compound heterozygous individuals with primary ciliary dyskiensia (Antony D et al. Hum Mutat, 2013 Mar;34:462-72; Davis SD et al. Am J Respir Crit Care Med, 2019 01;199:190-198). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | This sequence change creates a premature translational stop signal (p.Arg599*) in the CCDC39 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCDC39 are known to be pathogenic (PMID: 21131972, 23255504). This variant is present in population databases (rs201780665, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with primary ciliary dyskinesia (PMID: 23255504, 24498942). ClinVar contains an entry for this variant (Variation ID: 455014). For these reasons, this variant has been classified as Pathogenic. - |
Primary ciliary dyskinesia 14 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota | Nov 24, 2020 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Jan 21, 2022 | - - |
Ellis-van Creveld syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Rare Disease Group, Clinical Genetics, Karolinska Institutet | May 01, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at